3 - After the trial

Life long treatment

All patients enrolled in a clinical trial should be provided the best proven therapy for a life long period. This means that, all patients who partake in the trials, including those in the control arms, are to be given free access to the combination proven effective by the trial, for a life time period. Similarly, patients must be given free access to every other drug in their treatment combination , even if this other drug is produced by another company. As treatment drugs and combination may change over time, past trial participants should automatically become eligible to new, improved medication as it becomes available. The same treatment options and rights must be extended also to patients forced to leave the trial prior to its completion, due to of tolerability / toxicity or other problems.

European AIDS Treatmen.../Publications/Archive/EATN/Volume 14, I – Spring.../EATG's position paper.../
Print